Publicaciones en colaboración con investigadores/as de University of Innsbruck (27)

2026

  1. Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial

    European Radiology

  2. Asundexian for Secondary Stroke Prevention

    The New England journal of medicine, Vol. 394, Núm. 15, pp. 1467-1479

  3. Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy

    BJU International, Vol. 137, Núm. 2, pp. 270-281

  4. Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups

    BJU International, Vol. 137, Núm. 5, pp. 866-876

  5. Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention

    European stroke journal, Vol. 11, Núm. 1

2025

  1. Health Status Outcomes After Computed Tomography or Invasive Coronary Angiography for Stable Chest Pain A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial

    JAMA Cardiology, Vol. 10, Núm. 7, pp. 728-739

  2. State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres

    Molecular Genetics and Metabolism, Vol. 145, Núm. 3

2024

  1. All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study

    The Lancet Regional Health - Europe, Vol. 44

  2. FIGO 2023 staging for endometrial cancer, when, if it is not now?

    European Journal of Cancer, Vol. 213

  3. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

  4. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

    The Lancet Neurology, Vol. 23, Núm. 5, pp. 465-476

  5. Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration

    Clinical Infectious Diseases, Vol. 79, Núm. 5, pp. 1242-1257

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19

    Transplantation, Vol. 106, Núm. 5, pp. 1012-1023

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

    HIV Medicine, Vol. 23, Núm. 6, pp. 684-692

  4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  5. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1